LEPROTL1
Leptin receptor overlapping transcript-like 1
Also known as: LERL1_HUMAN, my047, Vps55
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95214
- Gene
- LEPROTL1
- Ensembl
- ENSG00000104660
- Chromosome
- 8
- Canonical length
- 131 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Enables identical protein binding activity. Predicted to be involved in late endosome to vacuole transport via multivesicular body sorting pathway and negative regulation of growth hormone receptor signaling pathway. Predicted to be located in membrane. Predicted to be active in endosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
131 residues, UniProt reviewed canonical sequence.
>O95214|LEPROTL1
1 MAGIKALISL SFGGAIGLMF LMLGCALPIY NKYWPLFVLF FYILSPIPYC IARRLVDDTD
61 AMSNACKELA IFLTTGIVVS AFGLPIVFAR AHLIEWGACA LVLTGNTVIF ATILGFFLVF
121 GSNDDFSWQQ WLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LEPROTL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 71 nTPM
Expression across tissuesHPA
Tissue
- placenta: 71 nTPM
- thymus: 62 nTPM
- bone marrow: 53 nTPM
- adrenal gland: 44 nTPM
- lymph node: 37 nTPM
- liver: 35 nTPM
Single-cell type
- t-cells: 518 nCPM
- gastric progenitor cells: 296 nCPM
- nk-cells: 268 nCPM
- late primary spermatocytes: 258 nCPM
- innate lymphoid cells: 242 nCPM
- mast cells: 190 nCPM
Immune cell
- naive CD4 T-cell: 350 nTPM
- T-reg: 341 nTPM
- total PBMC: 285 nTPM
- naive CD8 T-cell: 262 nTPM
- basophil: 255 nTPM
- memory CD4 T-cell: 248 nTPM
Brain region
- cerebellum: 44 nTPM
- cerebral cortex: 43 nTPM
- hippocampal formation: 43 nTPM
- white matter: 41 nTPM
- basal ganglia: 39 nTPM
- hypothalamus: 38 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0.72
- gnomAD missense Z
- 0.94
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- late endosome to vacuole transport via multivesicular body sorting pathway
- negative regulation of growth hormone receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LEPROTL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LEPROTL1 as an antibody target. Whether an autoantibody or antibody against LEPROTL1 could matter depends on whether native LEPROTL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LEPROTL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LEPROTL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...